Bristol-Myers Squibb Secures Patent on Amino Indole Compounds Useful as TLR Inhibitors

Published date20 April 2022
The abstract released by U.S. Patent and Trademark Office states, "Disclosed are compounds of Formula (I) or salts thereof, wherein G, R1, R5, R7, R8, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT